by Nathaniel Harding | Feb 22, 2024 | Media
Nathan Den Herder, CEO and Founder of Ardley sits down for an exclusive interview to discuss the launch of their cutting-edge autopilot underwriting engine. Featured in top publications, including Housingwire, Mortgage Bankers Association, National Mortgage News and...
by Nathaniel Harding | Feb 12, 2024 | Media
Our Principal, Susan Moring, joined CorriXR CEO, Deborah Moorad and CorriXR’s Founder and CSO, Eric B. Kmiec, in an exclusive interview with OETA. This insightful interview highlights the pioneering efforts this amazing company is making in transforming gene editing...
by Nathaniel Harding | Feb 7, 2024 | Media
We are excited to share an exclusive feature published by Axios on Lumata Health on their Series A+ funding round from 2023. We are proud to have one of our spectacular portfolio companies featured in such a reputable publication, and we look forward to continued...
by Nathaniel Harding | Feb 7, 2024 | Media
This article discusses the impact of the Federal Reserve’s decision not to cut interest rates and its implications for various sectors, including venture capital (VC). The Federal Reserve’s indication that rate cuts are unlikely in the near future has led...
by Cortado Ventures Media | Jan 29, 2024 | Blog, Media, Portfolio Companies
Why We Invested: Lumata Health Pioneering Next-Generation Eye Care Authored by Cody Merrill At Cortado Ventures, we are in the venture capital business of maximizing risk-adjusted returns with high-potential, early-stage startups. We seek...
by Nathaniel Harding | Jan 22, 2024 | Media
FOR IMMEDIATE RELEASE Jan. 16, 2024 Contact: Anthony Triana atriana@saxum.com (Direct) 405.818.0791 Cortado Ventures Invests in CorriXR: A Groundbreaking Gene-Editing Company with Initial Focus on Oncology OKLAHOMA CITY – Cortado Ventures, a...
